Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Dev Neuropsychol ; 41(4): 245-260, 2016.
Article in English | MEDLINE | ID: mdl-27805419

ABSTRACT

This systematic review and meta-analysis (MA) investigates the impact of elevated blood phenylalanine (Phe) on neuropsychiatric symptoms in adults with phenylketonuria (PKU). The meta-analysis of PKU is challenging because high-quality evidence is lacking due to the limited number of affected individuals and few placebo-controlled, double-blind studies of adults with high and low blood Phe. Neuropsychiatric symptoms associated with PKU exceed general population estimates for inattention, hyperactivity, depression, and anxiety. High Phe is associated with an increased prevalence of neuropsychiatric symptoms and executive functioning deficits whereas low Phe is associated with improved neurological performance. Findings support lifelong maintenance of low blood Phe.


Subject(s)
Executive Function/physiology , Mental Disorders/physiopathology , Phenylalanine/blood , Phenylketonurias/complications , Adolescent , Adult , Humans , Mental Disorders/etiology , Phenylketonurias/blood , Young Adult
2.
Vet Microbiol ; 111(1-2): 1-13, 2005 Nov 30.
Article in English | MEDLINE | ID: mdl-16181751

ABSTRACT

Costimulatory ligands, B7.1 and B7.2, have been incorporated into viral and DNA vectors as potential nonchemical adjuvants to enhance CTL and humoral immune responses against viral pathogens. In addition, soluble B7 proteins, minus their transmembrane and cytoplasmic domains, have been shown to block the down regulation of T-cell activation through blockade of B7/CTLA-4 interactions in mouse tumor models. Recently, we developed swinepox virus (SPV) vectors for delivery of feline leukemia antigens for vaccine use in cats [Winslow, B.J., Cochran, M.D., Holzenburg, A., Sun, J., Junker, D.E., Collisson, E.W., 2003. Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin. Virus Res. 98, 1-15]. To explore the use of feline B7.1 and B7.2 ligands as nonchemical adjuvants, SPV vectors containing full-length feline B7.1 and B7.2 ligands were constructed and analyzed. Full-length feline B7.1 and B7.2 produced from SPV vectors were natively processed and costimulated Jurkat cells to produce IL-2, in vitro. In addition, we explored the feasibility of utilizing SPV as a novel expression vector to produce soluble forms of feline B7.1 (sB7.1) and B7.2 (sB7.2) in tissue culture. The transmembrane and cytoplasmic regions of the B7.1 and B7.2 genes were replaced with a poly-histidine tag and purified via a two-step chromatography procedure. Receptor binding and costimulation activity was measured. Although feline sB7.1-his and sB7.2-his proteins bound to the human homolog receptors, CTLA-4 and CD28, both soluble ligands possessed greater affinity for CTLA-4, compared to CD28. However, both retained the ability to partially block CD28-mediated costimulation in vitro. Results from these studies establish the use of SPV as a mammalian expression vector and suggest that full-length-vectored and purified soluble feline B7 ligands may be valuable, nonchemical immune-modulators.


Subject(s)
Adjuvants, Immunologic , B7-1 Antigen/immunology , B7-2 Antigen/immunology , Poxviridae Infections/veterinary , Suipoxvirus/immunology , Animals , Antigens, CD , Antigens, Differentiation , B7-1 Antigen/genetics , B7-2 Antigen/genetics , CTLA-4 Antigen , Cats , Cell Line , Gene Products, env/metabolism , Gene Products, gag/metabolism , Genetic Vectors , Humans , Immunoconjugates , Interleukin-2/biosynthesis , Jurkat Cells , Leukemia, Feline/prevention & control , Lymphocyte Activation , Poxviridae Infections/immunology , Virus Replication
3.
Vet Immunol Immunopathol ; 99(1-2): 25-37, 2004 May.
Article in English | MEDLINE | ID: mdl-15113651

ABSTRACT

Lymph node (LN) T cells from feline immunodeficiency virus (FIV)-infected cats have an increased expression of B7 co-stimulatory molecules as well as their ligand CTLA4, resembling an activation phenotype shown to induce anergy and apoptosis in activated T cells. In addition, LN T cells from FIV-infected cats also show increased spontaneous apoptosis compared to uninfected animals. The apoptosis observed in these animals occurs primarily in T cells expressing B7 and CTLA4, suggesting a role for B7 and CTLA4 interactions in the induction of anergy/apoptosis. In order to investigate the role of B7 and CTLA4 interactions on T cell apoptosis in LN T cells from FIV-infected cats, we performed blocking experiments by measuring T cell apoptosis in LN T cell cultures treated with anti-feline B7.1, B7.2, and CTLA4 specific antibodies, as well as interleukin (IL)-2. The addition of IL2, the primary cytokine produced by B7/CD28 interactions, resulted in a significant decrease of T cell apoptosis in cultured LN cells as assessed by two-color flow cytometry and TUNEL assay. The addition of anti-B7.1 antibodies significantly inhibited T cell apoptosis in FIV-infected cats with low-level plasma viremia, while addition of anti-B7.2 and anti-CTLA4 antibodies had no affect. These results suggest a role of B7 signaling in the increased spontaneous apoptosis observed in LN T cells from FIV-infected animals.


Subject(s)
Apoptosis/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Feline Acquired Immunodeficiency Syndrome/immunology , Immunodeficiency Virus, Feline/immunology , Interleukin-2/pharmacology , Membrane Glycoproteins/antagonists & inhibitors , Animals , Antibodies, Blocking/immunology , Antigens, CD/immunology , Apoptosis/drug effects , B7-2 Antigen , CD4-Positive T-Lymphocytes/pathology , CD4-Positive T-Lymphocytes/virology , CD8-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/virology , Cats , Feline Acquired Immunodeficiency Syndrome/blood , Immunodeficiency Virus, Feline/genetics , In Situ Nick-End Labeling/veterinary , Interleukin-2/immunology , Lymph Nodes/immunology , Lymphocyte Activation/immunology , Membrane Glycoproteins/immunology , RNA, Viral/chemistry , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Specific Pathogen-Free Organisms
4.
Vet Immunol Immunopathol ; 98(3-4): 203-14, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15010229

ABSTRACT

Apoptosis in lymph node (LN) T cells of feline immunodeficiency virus (FIV)-infected cats is associated with cells co-expressing B7.1 and B7.2 costimulatory molecules, and their ligand CTLA4. To study the possibility of B7.1/B7.2-CTLA4 mediated T-T interactions and the predicted induction of T cell apoptosis in vitro, costimulatory molecules were up-regulated on CD4+ and CD8+ T cells by mitogen stimulation. B7.1 expression on in vitro stimulated CD4+ and CD8+ cells increased within 24h; B7.2 and CTLA4 expression increased after 48-72 h. Apoptosis, as analyzed by terminal deoxynucleotidyl transferase (transferase nick end labeling, TUNEL)-based staining followed by three color flow cytometric analysis, correlated to the cells expressing B7 and/or CTLA4. Blocking experiments revealed that CD4+ and CD8+ T cell apoptosis could be significantly inhibited with anti-B7 antibodies. As FIV infection results in immune activation with a T cell phenotype similar to that of the in vitro activated T cells, the data support the hypothesis that the chronic expansion of B7+CTLA4+ LN T cells in infected cats allows for T-T cell interactions resulting in T cell depletion and eventually the development of AIDS.


Subject(s)
Antigens, Differentiation/immunology , Apoptosis/immunology , Feline Acquired Immunodeficiency Syndrome/immunology , Immunodeficiency Virus, Feline/immunology , T-Lymphocytes/immunology , Animals , Antigens, CD/biosynthesis , Antigens, CD/immunology , Antigens, Differentiation/biosynthesis , B7-1 Antigen/biosynthesis , B7-1 Antigen/immunology , B7-2 Antigen , CTLA-4 Antigen , Cats , Cell Communication/immunology , Concanavalin A/immunology , Flow Cytometry/veterinary , In Situ Nick-End Labeling/veterinary , Ionomycin/immunology , Lymphocyte Activation/immunology , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/immunology , Specific Pathogen-Free Organisms , T-Lymphocytes/virology , Tetradecanoylphorbol Acetate/immunology
5.
Virus Res ; 98(1): 1-15, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14609625

ABSTRACT

The host range of swinepox virus (SPV) is restricted to swine, although SPV has been shown to infect mammalian, non-swine cells, without recovery of infectious virus. SPV is a reasonable candidate for development as a non-productively replicating viral vector for use in non-swine, mammalian species, such as the cat. A novel SPV gene deletion (SPV 043) was created and found to be non-attenuating. This deletion was utilized to generate a stable recombinant virus expressing the Gag-Pro and Env proteins of feline leukemia virus (FeLV). Expression and replication of this vector was studied in embryonic swine kidney cells (ESK-4), and two feline cell lines, Crandell feline kidney cells (CRFK) and feline skin fibroblasts (FSF). Our results showed that feline cells were susceptible to infection by SPV and supported expression of foreign genes driven by synthetic poxvirus promoters, however, SPV viral DNA was not replicated in feline cells and infectious virus was not recovered. In addition, FeLV Gag virus-like particles were produced from both ESK-4 and CRFK cells and foreign antigens were incorporated into infectious SPV intracellular mature virions (IMV). These results suggest that SPV may have potential as a safe vaccine delivery vector for cats.


Subject(s)
Gene Products, env/metabolism , Gene Products, gag/metabolism , Genetic Vectors , Leukemia Virus, Feline/genetics , Virus Replication , Animals , Base Sequence , Cats , Cell Line , Gene Products, env/genetics , Gene Products, gag/genetics , Leukemia Virus, Feline/metabolism , Molecular Sequence Data , Suipoxvirus/genetics , Suipoxvirus/physiology , Swine , Virion/metabolism
6.
J Infect Dis ; 185(8): 1077-93, 2002 Apr 15.
Article in English | MEDLINE | ID: mdl-11930318

ABSTRACT

The B7.1 and B7.2 costimulatory molecules on antigen-presenting cells provide second signals for regulating T cell immune responses via CD28 and cytotoxic T lymphocyte antigen 4 (CTLA4) on T cells. CD28 signals cell proliferation, whereas CTLA4 signals for anergy or apoptosis, terminating the immune response. Because T cell apoptosis and immunodeficiency is a characteristic of feline immunodeficiency virus (FIV)-infected cats, it is possible that negative T cell signaling via B7 and CTLA4 may be favored in these cats. Flow cytometry revealed high percentages of CD8+ and CD4+ cells expressing B7.1, B7.2, and CTLA4 in lymph nodes of FIV-positive cats and a large fraction of CTLA4+ T cells coexpressing B7.1 and B7.2. Three-color analysis with anti-B7.1, anti-B7.2, or anti-CTLA4 and TUNEL (terminal deoxynucleotidyl transferase nick-end-labeling) analysis revealed that apoptosis was a characteristic of B7.1+ B7.2+ CTLA4+ T cells. These data support the hypothesis that lymph node apoptosis and immune deterioration in FIV-infected cats results from chronic B7.1- and/or B7.2-CTLA4-mediated T-T interactions.


Subject(s)
Antigens, CD/analysis , Antigens, Differentiation/analysis , Apoptosis , B7-1 Antigen/analysis , Feline Acquired Immunodeficiency Syndrome/immunology , Immunoconjugates , Membrane Glycoproteins/analysis , T-Lymphocytes/physiology , Abatacept , Animals , B7-2 Antigen , CTLA-4 Antigen , Cats , In Situ Nick-End Labeling
SELECTION OF CITATIONS
SEARCH DETAIL
...